相关实验视频
Updated: Jul 26, 2025

09:42
Comprehensive Analysis of Drug Response using the FLICK Assay
Published on: June 6, 2025
232
对givinostat进行的人口药理动力学分析
Francesco Fiorentini1, Massimiliano Germani2, Francesca Del Bene3
1Pharmacokinetics, Accelera, Milan, Italy.
Expert opinion on drug metabolism & toxicology
|June 12, 2023
概括
基诺斯塔特,一个组织素脱乙酶抑制剂,改善了杜申肌肉发育不良 (DMD) 的男孩的肌肉活检参数. 基于体重的剂量和血小板监测将支持其在III期试验中的有效性和安全性.
科学领域:
- 药理动力学和药理动力学
- 基斯脱乙酶抑制剂 基斯脱乙酶抑制剂
- 杜恩肌肉衰竭研究研究
背景情况:
- 吉维诺斯塔特 (ITF2357) 是一种口服的胰岛素脱乙酶抑制剂.
- 第二阶段研究表明,吉维诺斯塔特改善了杜申肌肉发育不良 (DMD) 的男孩的肌肉活检参数.
研究的目的:
- 开发一个群体药理动力学 (PK) 模型用于givinostat.
- 模拟儿科的剂量建议.
- 建立一个PK/药理动力学 (PD) 模型,将givinostat度与儿童血小板计数联系起来.
主要方法:
- 利用七项临床研究的数据构建了PK模型.
- 开发了一种具有第一阶级输入和滞后的两部分PK模型.
- 创建了一个PK/PD模型来描述血小板数量随时间变化.
主要成果:
- 显而易见的givinostat清除随着体重增加而增加.
- 该PK/PD模型准确地描述了血小板计数的动态.
- 基于体重的剂量导致28天内血小板数量平均下降45%,患者出现严重的血小板缺血的情况很少.
结论:
- 基维诺斯塔特的剂量将根据体重进行调整.
- 血小板计数监测对于确保givinostat的安全性和有效性至关重要.
- 这些发现支持在DMDIII期研究中使用givinostat.
相关概念视频
Analysis of Population Pharmacokinetic Data
306
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
306
Pharmacokinetics: Overview
6.6K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
6.6K
Noncompartmental Analysis: Miscellaneous Pharmacokinetic Parameters
136
The noncompartmental approach is a widely used method in pharmacokinetics to assess drugs' behaviors in the body. It considers several factors, including clearance, bioavailability, and total volume of distribution.
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
One key aspect of the noncompartmental approach is determining a drug's total clearance. This can be done by dividing the drug dose by the area under the concentration-time curve from zero to infinity. The area under the concentration-time curve represents the drug's...
136
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
64
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
A recent model describes pravastatin's hepatobiliary excretion,...
64
Pharmacokinetic Models: Overview
818
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
818
Nonlinear Pharmacokinetics: Overview
456
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
456

